INE571A01038
INE571A01038
IPCA LABORATORIES LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 485.95B EUR | 431.58B EUR | 406.23B EUR | 359.99B EUR |
Enterprise Value | 496.68B EUR | 431.58B EUR | 409.95B EUR | 359.99B EUR |
Valuation Multiples | ||||
Trailing P/E | 37.1x | 32.95x | 35.6x | 42.75x |
Forward P/E | 27.21x | -- | -- | -- |
Price to Sales | 4.8x | 4.26x | 4.21x | 4.96x |
Price to Book | 6.03x | -- | 5.04x | -- |
EV/Revenue | 4.91x | 4.26x | 4.25x | 4.96x |
EV/EBITDA | 22.02x | 17.99x | 19.04x | 22.85x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |